ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
PTC inks $200M Agilis takeover to snag late-phase gene therapy
fiercebiotech
July 26, 2018PTC Therapeutics is paying $200 million upfront to acquire Agilis Biotherapeutics. The deal gives PTC ownership of a gene therapy treatment for rare neurotransmitter disease AADC deficiency that is set to go before the FDA next year.
Pharma Sources Insight January 2025
